ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 689865 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 689865; 2) Community: the network communities that were significantly associated with the response to NSC 689865; 3) Molecule: the relationships between components within communities and NSC 689865; 4) MDR: the compounds that were significantly associated with the NSC 689865.

NSC Compound Enrichment Correlation
NSC 302035 Melampodin B acetate 0.0119221520283057 0.26679366
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.0119221520283057 0.34989294
NSC 622700 Methanaminium, (2-oxo-1,3-cyclohexanediyl)bis(methyl)bis [N,N,N-trimethyl-, diiodide 0.0119221520283057 0.38811225
NSC 668257 2,4(1H,3H)-Pyrimidinedione, 1-[[2-(4-chlorophenyl)- tetrahydro-4-methylene-5-oxo-2-furanyl]methyl]-5-methyl- 0.0119221520283057 0.37461779
NSC 619031 Analog of CC-1065 0.0119221520283058 0.2459579
NSC 623433 OVB3-PE 0.0119221520283058 -0.073363243
NSC 140873 2-Amino-N-(4-chloro-2-(1H-pyrrole-2-carbonyl)phenyl)acetamide 0.0122129861493296 0.34501011
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0122129861493296 0.45475241
NSC 176323 Camptothecin Derivative 0.0122129861493296 0.3156187
NSC 335753 HELIANGOLIDE 0.0122129861493296 0.52082453
Total:138  Current:52    [First] [Prev] [Next] [Last]